Foreign drugmakers spur OTC sales

Multinational drug manufacturers, including Wyeth and Novartis, are focusing on boosting the sales of their flagship OTC (over-the-counter) drugs by offering a variety of incentives.

Facing the massive drug price cuts starting April, they are doing their utmost to cope with the crisis.

While trying to cut various costs on the one hand, they are also stepping up efforts to increase the sal...